American Journal of Medical and Clinical Research & Reviews

Treatment of hair loss with an LED device: the importance of the wave length

Hausdorfer S — 2026-03-01

Hair loss is of a big concern in our society, concerning about 50% of the population at one time of their life. It impacts social integration and the feeling of well-being.

We will distinguish hair loss with and without inflammatory causes, both having to be treated differently. Number of sessions, wave lengths, and energy levels will be discussed. Red light (630 nm) alone will be used in hair loss without inflammation, such is seen in crash dieting, postpartum, or after chemotherapy. The combination of IR-red light is necessary to have conclusive results in the other case, such as alopecia areata. The presence of hair bulbs is necessary to achieve regrowth. Instead of biopsies in already scarce hair, I performed clinical photographs, always in the same position; one before treatment, one after 5 sessions, and one after ten sessions. If necessary, treatment could be continued once a month.

This is a retrospective review of more than 600 cases, successfully treated in my praxis. The effects are durable, in time except in pathologies with an inflammatory component where a couple of new treatment sessions are necessary.

Using this method in every day practice is very easy as treatment sessions take about 15 minutes and the method is very successful when applied correctly. The treatment is very safe with virtually no side effects and permits to reduce other medication used for this purpose.

A Comment of Osteoarthritis of Knee

Saccomanni Bernardino — 2026-03-01

Vaccination Strategies in Adult Dialysis Patients: A Global, Temperate‑Tropical Epidemiological Feature

Anita L R Saldanha — 2026-03-01

Background: Patients receiving maintenance dialysis have elevated risks of vaccine‑preventable infections and reduced vaccine immunogenicity due to uremia‑associated immune dysfunction and repeated healthcare exposure. Geographic variation in infectious burden influences vaccination strategy implementation.

Objective: To comprehensively review immunization procedures in adult dialysis patients, integrating immunologic mechanisms, clinical effectiveness, global epidemiologic variation (temperate vs tropical differences), and implementation practices.

Methods: Narrative synthesis of systematic reviews, clinical studies, and expert recommendations pertaining to vaccine immunogenicity and clinical outcomes in chronic kidney disease and dialysis populations.

Results: Enhanced hepatitis B vaccine regimens improve seroprotection and survival. Combined influenza and pneumococcal vaccination are associated with reduced all‑cause mortality in dialysis patients. COVID‑19 vaccination elicits robust humoral responses with acceptable safety profiles, though effectiveness is lower than in healthy controls. Tropical regions face higher endemic burdens of hepatitis B and year‑round influenza, requiring context‑adapted protocols. Implementation science suggests dialysis‑unit–based vaccination programs improve uptake and outcomes.

Conclusion: Immunization in dialysis patients requires higher‑dose regimens, booster strategies, and context‑specific adaptation to regional epidemiologic patterns. Dialysis facilities should adopt structured vaccination frameworks to reduce infection‑related morbidity and mortality globally.